Neogen Corp (NEOG)
12.44
+0.39
(+3.24%)
USD |
NASDAQ |
May 09, 16:00
12.44
0.00 (0.00%)
Pre-Market: 20:00
Neogen Market Cap: 2.695B for May 9, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.695B |
| May 08, 2024 | 2.610B |
| May 07, 2024 | 2.688B |
| May 06, 2024 | 2.630B |
| May 03, 2024 | 2.604B |
| May 02, 2024 | 2.697B |
| May 01, 2024 | 2.653B |
| April 30, 2024 | 2.671B |
| April 29, 2024 | 2.690B |
| April 26, 2024 | 2.630B |
| April 25, 2024 | 2.591B |
| April 24, 2024 | 2.679B |
| April 23, 2024 | 2.666B |
| April 22, 2024 | 2.552B |
| April 19, 2024 | 2.515B |
| April 18, 2024 | 2.584B |
| April 17, 2024 | 2.630B |
| April 16, 2024 | 2.634B |
| April 15, 2024 | 2.601B |
| April 12, 2024 | 2.682B |
| April 11, 2024 | 2.816B |
| April 10, 2024 | 2.708B |
| April 09, 2024 | 2.825B |
| April 08, 2024 | 3.115B |
| April 05, 2024 | 3.108B |
| Date | Value |
|---|---|
| April 04, 2024 | 3.050B |
| April 03, 2024 | 3.089B |
| April 02, 2024 | 3.139B |
| April 01, 2024 | 3.266B |
| March 28, 2024 | 3.418B |
| March 27, 2024 | 3.349B |
| March 26, 2024 | 3.249B |
| March 25, 2024 | 3.290B |
| March 22, 2024 | 3.295B |
| March 21, 2024 | 3.347B |
| March 20, 2024 | 3.379B |
| March 19, 2024 | 3.273B |
| March 18, 2024 | 3.264B |
| March 15, 2024 | 3.288B |
| March 14, 2024 | 3.303B |
| March 13, 2024 | 3.381B |
| March 12, 2024 | 3.448B |
| March 11, 2024 | 3.507B |
| March 08, 2024 | 3.546B |
| March 07, 2024 | 3.630B |
| March 06, 2024 | 3.624B |
| March 05, 2024 | 3.630B |
| March 04, 2024 | 3.734B |
| March 01, 2024 | 3.723B |
| February 29, 2024 | 3.723B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.207B
Minimum
Aug 24 2022
5.173B
Maximum
Apr 20 2021
3.816B
Average
3.778B
Median
Sep 05 2019
Market Cap Benchmarks
| Moderna Inc | 47.02B |
| Regeneron Pharmaceuticals Inc | 106.66B |
| Syros Pharmaceuticals Inc | 133.33M |
| Disc Medicine Inc | 758.18M |
| Amylyx Pharmaceuticals Inc | 127.43M |
Market Cap Related Metrics
| PE Ratio | 2157.10 |
| PS Ratio | 2.900 |
| Price to Book Value | 0.8565 |
| Price | 12.44 |
| Earnings Yield | 0.05% |
| Operating PE Ratio | 39.02 |
| Normalized PE Ratio | 591.85 |